ADORA2A and diffuse large B-cell lymphoma: Another study found a strong synergistic combinatorial effect between adenosine A2A receptor agonists and cAMP‐hydrolyzing PDE inhibitors in MM and diffuse large B‐cell lymphoma cell lines and primary patient samples [41].